---
title: "301331.SZ (301331.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301331.SZ/news.md"
symbol: "301331.SZ"
name: "301331.SZ"
parent: "https://longbridge.com/en/quote/301331.SZ.md"
datetime: "2026-03-13T20:32:08.157Z"
locales:
  - [en](https://longbridge.com/en/quote/301331.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301331.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301331.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301331.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301331.SZ/news.md)


# 301331.SZ (301331.SZ) — Related News

### [Major positive news! This sector leads the market against the trend](https://longbridge.com/en/news/275064785.md)
*2026-02-06T02:57:47.000Z*
> Today (February 6), the major market indices opened lower. On the market, the traditional Chinese medicine sector rose a

### [ENWEI PHARMACEUTICAL issued a profit forecast, expecting a net profit attributable to the parent company of 56.5 million to 66.5 million yuan for the fiscal year 2025, an increase of 50.68% to 77.35%](https://longbridge.com/en/news/273073496.md)
*2026-01-20T11:07:03.000Z*
> ENWEI PHARMACEUTICAL expects the net profit attributable to shareholders for the fiscal year 2025 to be between 56.5 mil

### [ENWEI PHARMACEUTICAL: Based on 102 million shares, a cash dividend of RMB 3.5 will be distributed to all shareholders for every 10 shares](https://longbridge.com/en/news/271085825.md)
*2025-12-30T09:19:05.000Z*
> ENWEI PHARMACEUTICAL announced that the company's interim dividend distribution plan for 2025 is as follows: Based on th

### [ENWEI PHARMACEUTICAL: A cash dividend of 3.5 yuan will be distributed for every 10 shares](https://longbridge.com/en/news/270839107.md)
*2025-12-26T09:48:22.000Z*
> ENWEI PHARMACEUTICAL announced that the company's interim dividend plan for 2025 is to distribute a cash dividend of 3.5

### [ENWEI PHARMACEUTICAL: ENWEI Group pledged 5 million company shares](https://longbridge.com/en/news/266699675.md)
*2025-11-20T09:28:45.000Z*
> ENWEI PHARMACEUTICAL announced that its controlling shareholder, ENWEI GROUP, pledged 5 million company shares, accounti

### [ENWEI PHARMACEUTICAL plans to invest 20 million yuan in Jiaxing Panlin Jiayi Venture Capital Partnership](https://longbridge.com/en/news/265902635.md)
*2025-11-14T11:07:02.000Z*
> ENWEI PHARMACEUTICAL announced an investment of 20 million yuan in Jiaxing Panlin Jiayi Venture Capital Partnership, bec

### [ENWEI PHARMACEUTICAL: Vice President completes a reduction of 0.0157%](https://longbridge.com/en/news/254998096.md)
*2025-08-28T11:50:32.000Z*
> ENWEI PHARMACEUTICAL announced that Vice President Chen Lei has reduced his holdings in the company by 16,200 shares thr

### [](https://longbridge.com/en/news/254352391.md)
*2025-08-25T01:52:00.000Z*
> The A-share traditional Chinese medicine sector rapidly surged, with Xintian Pharma hitting the limit up, and YIBAI PHAR

### [ENWEI PHARMACEUTICAL: The research product QianKunNing tablets is an innovative traditional Chinese medicine used for the treatment of mild COVID-19 infections](https://longbridge.com/en/news/252427502.md)
*2025-08-11T05:50:19.000Z*
> ENWEI PHARMACEUTICAL stated on the interactive platform that its research product QianKunNing tablets is an innovative t